TeraView develops terahertz instruments which can generate, detect and manipulate radiation to characterize a wide range of materials.
TeraView is the world’s first company devoted to the application of Terahertz light for imaging and spectroscopy. TeraView’s proprietary platform uses the Terahertz spectrum between light and radio waves and offers the advantage of being non-invasive and non-destructive. A key application of the technology is the detection of faults and quality variations in semiconductor integrated circuits. In addition, studies have demonstrated how Terahertz uniquely and non invasively provides 3 dimensional structural and chemical information in a diverse range of applications, including weapons/explosives hidden below clothing, the contents of tablets and capsules in the pharmaceutical industry, and other objects normally invisible to conventional detection techniques. Other markets for the technology exist in medical imaging of cancer and industrial inspection which are explored via commercial partners. Headquartered in Cambridge, UK, TeraView was spun-out of the Toshiba Cambridge Research Laboratory in April 2001. Sales and support are available throughout Europe, North America and the Far East either directly or through a network of distributors.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 26, 2012 | Series Unknown | $5.50M | 1 | New Hill Management | — | Detail |
Jan 14, 2004 | Series B | £6M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
New Hill Management | Yes | Series Unknown |
The Cambridge Gateway Fund | — | Series B |